193 related articles for article (PubMed ID: 10408384)
1. C1-inhibitor attenuates hyperacute rejection and inhibits complement, leukocyte and platelet activation in an ex vivo pig-to-human perfusion model.
Fiane AE; Videm V; Johansen HT; Mellbye OJ; Nielsen EW; Mollnes TE
Immunopharmacology; 1999 May; 42(1-3):231-43. PubMed ID: 10408384
[TBL] [Abstract][Full Text] [Related]
2. Compstatin, a peptide inhibitor of C3, prolongs survival of ex vivo perfused pig xenografts.
Fiane AE; Mollnes TE; Videm V; Hovig T; Høgåsen K; Mellbye OJ; Spruce L; Moore WT; Sahu A; Lambris JD
Xenotransplantation; 1999 Feb; 6(1):52-65. PubMed ID: 10355733
[TBL] [Abstract][Full Text] [Related]
3. Ex-vivo hemoperfusion (eHPS) of pig-lungs with whole human blood: effects of complement inhibition with a soluble C1-esterase-inhibitor.
Schelzig H; Simon F; Krischer C; Vogel A; Abendroth D
Ann Transplant; 2001; 6(3):34-9. PubMed ID: 11899895
[TBL] [Abstract][Full Text] [Related]
4. Effect of complement fragment 1 esterase inhibition on survival of human decay-accelerating factor pig lungs perfused with human blood.
Schröder C; Pfeiffer S; Wu G; Zorn GL; Ding L; Allen C; Harrison RA; White DJ; Azimzadeh AM; Pierson RN
J Heart Lung Transplant; 2003 Dec; 22(12):1365-75. PubMed ID: 14672751
[TBL] [Abstract][Full Text] [Related]
5. C1-inhibitor for prophylaxis of xenograft rejection after pig to cynomolgus monkey kidney transplantation.
Hecker JM; Lorenz R; Appiah R; Vangerow B; Loss M; Kunz R; Schmidtko J; Mengel M; Klempnauer J; Piepenbrock S; Dickneite G; Neidhardt H; Rückoldt H; Winkler M
Transplantation; 2002 Mar; 73(5):688-94. PubMed ID: 11907412
[TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin prolongs survival of pig kidneys perfused ex vivo with human blood.
Fiane AE; Videm V; Mellbye OJ; Foerster A; Geiran OR; Gladhaug IP; Svennevig JL; Mollnes TE
Scand J Immunol; 1998 Jun; 47(6):568-74. PubMed ID: 9652825
[TBL] [Abstract][Full Text] [Related]
7. Prevention of complement-mediated activation of xenogeneic endothelial cells in an in vitro model of xenograft hyperacute rejection by C1 inhibitor.
Dalmasso AP; Platt JL
Transplantation; 1993 Nov; 56(5):1171-6. PubMed ID: 8249120
[TBL] [Abstract][Full Text] [Related]
8. A surface-bound form of human C1 esterase inhibitor improves xenograft rejection.
Matsunami K; Miyagawa S; Yamada M; Yoshitatsu M; Shirakura R
Transplantation; 2000 Mar; 69(5):749-55. PubMed ID: 10755521
[TBL] [Abstract][Full Text] [Related]
9. A soluble chimeric inhibitor of C3 and C5 convertases, complement activation blocker-2, prolongs graft survival in pig-to-rhesus monkey heart transplantation.
Salerno CT; Kulick DM; Yeh CG; Guzman-Paz M; Higgins PJ; Benson BA; Park SJ; Shumway SJ; Bolman RM; Dalmasso AP
Xenotransplantation; 2002 Mar; 9(2):125-34. PubMed ID: 11897005
[TBL] [Abstract][Full Text] [Related]
10. C1-inhibitor and transplantation.
Kirschfink M
Immunobiology; 2002 Sep; 205(4-5):534-41. PubMed ID: 12396013
[TBL] [Abstract][Full Text] [Related]
11. Hyperacute rejection in ex vivo-perfused porcine lungs transgenic for human complement regulatory proteins.
Pöling J; Oezkur M; Kogge K; Mengel M; Niemann H; Winkler M; Haverich A; Wiebe K
Transpl Int; 2006 Mar; 19(3):225-32. PubMed ID: 16441772
[TBL] [Abstract][Full Text] [Related]
12. Aurintricarboxylic acid inhibits endothelial activation, complement activation, and von Willebrand factor secretion in vitro and attenuates hyperacute rejection in an ex vivo model of pig-to-human pulmonary xenotransplantation.
Kim HK; Kim JE; Wi HC; Lee SW; Kim JY; Kang HJ; Kim YT
Xenotransplantation; 2008; 15(4):246-56. PubMed ID: 18957047
[TBL] [Abstract][Full Text] [Related]
13. C1-Inh and heparan sulfate can prevent discordant rejection.
Di Stefano R; Frosini F; Scavuzzo M; Ambrogi M; Fagiolini A; Ferrari M; Pelosi G; Mosca F
Transplant Proc; 1994 Jun; 26(3):1172-3. PubMed ID: 8029876
[No Abstract] [Full Text] [Related]
14. Protection of porcine endothelial cells from complement-mediated cytotoxicity by the human complement regulators CD59, C1 inhibitor, and soluble complement receptor type 1. Analysis in a pig-to-human in vitro model relevant to hyperacute xenograft rejection.
Heckl-Ostreicher B; Wosnik A; Kirschfink M
Transplantation; 1996 Dec; 62(11):1693-6. PubMed ID: 8970634
[TBL] [Abstract][Full Text] [Related]
15. Effect of human natural xenoantibody depletion and complement inactivation on early pig kidney function.
Cruzado JM; Torras J; Riera M; Condom E; Lloberas N; Herrero I; Martorell J; Grinyó JM
Exp Nephrol; 1999; 7(3):217-28. PubMed ID: 10352362
[TBL] [Abstract][Full Text] [Related]
16. Expression of human CD59 in transgenic pig organs enhances organ survival in an ex vivo xenogeneic perfusion model.
Kroshus TJ; Bolman RM; Dalmasso AP; Rollins SA; Guilmette ER; Williams BL; Squinto SP; Fodor WL
Transplantation; 1996 May; 61(10):1513-21. PubMed ID: 8633381
[TBL] [Abstract][Full Text] [Related]
17. C1 inhibitor for prophylaxis of xenograft rejection after pig to cynomolgus monkey kidney transplantation.
Miyata Y; Platt JL
Transplantation; 2002 Mar; 73(5):675-7. PubMed ID: 11907409
[No Abstract] [Full Text] [Related]
18. A phase I/II placebo-controlled trial of C1-inhibitor for prevention of antibody-mediated rejection in HLA sensitized patients.
Vo AA; Zeevi A; Choi J; Cisneros K; Toyoda M; Kahwaji J; Peng A; Villicana R; Puliyanda D; Reinsmoen N; Haas M; Jordan SC
Transplantation; 2015 Feb; 99(2):299-308. PubMed ID: 25606785
[TBL] [Abstract][Full Text] [Related]
19. Immunopathology of hyperacute xenograft rejection in a swine-to-primate model.
Platt JL; Fischel RJ; Matas AJ; Reif SA; Bolman RM; Bach FH
Transplantation; 1991 Aug; 52(2):214-20. PubMed ID: 1871792
[TBL] [Abstract][Full Text] [Related]
20. C1-inhibitor for therapy and prophylaxis of acute vascular rejection of porcine kidneys in cynomolgus monkeys.
Hecker JM; Loss M; Klempnauer J; Winkler M
Transplant Proc; 2002 Sep; 34(6):2382. PubMed ID: 12270447
[No Abstract] [Full Text] [Related]
[Next] [New Search]
